Gene · 2115
Papers2,342
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,342
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PEA3 Transcription Factors, Role in Invasion, Proliferation and Radioresistance of Glioblastoma Stem Cells. | J Cell Mol Med | 2025 | 40275610 | PubTator, text mining | PubMed |
| TF Profiler: a transcription factor inference method that broadly measures transcription factor activity and identifies mechanistically distinct networks. | Genome Biol | 2025 | 40205447 | PubTator, text mining | PubMed |
| Development of p300-targeting degraders with enhanced selectivity and onset of degradation. | RSC Med Chem | 2025 | 40093518 | PubTator, text mining | PubMed |
| ETVs dictate hPSC differentiation by tuning biophysical properties. | Nat Commun | 2025 | 40011454 | PubTator, text mining | PubMed |
| The mutational landscape and its longitudinal dynamics in relapsed and refractory classic Hodgkin lymphoma. | Ann Hematol | 2025 | 39992429 | PubTator, text mining | PubMed |
| lncRNA TCONS_00251376 promotes the proliferation and migration of gastric cancer cell through upregulating ETV1. | Cancer Innov | 2025 | 39668941 | PubTator, text mining | PubMed |
| Identification and Characterization of Key Genes Associated with Amelogenesis. | Eur J Dent | 2025 | 39299262 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the potential of PEA3 subfamily genes as tumor markers. | Sci Rep | 2024 | 39732961 | PubTator, text mining | PubMed |
| TriTan: an efficient triple nonnegative matrix factorization method for integrative analysis of single-cell multiomics data. | Brief Bioinform | 2024 | 39581871 | PubTator, text mining | PubMed |
| Elevated ETV4 expression in cholangiocarcinoma is linked to poor prognosis and may guide targeted therapies. | World J Gastrointest Oncol | 2024 | 39554735 | PubTator, text mining | PubMed |
| Prognostic value of PEA3 subfamily gene expression in cholangiocarcinoma. | World J Gastrointest Oncol | 2024 | 39350976 | PubTator, text mining | PubMed |
| Interindividual Variation in Gut Nitrergic Neuron Density Is Regulated By GDNF Levels and ETV1. | Cell Mol Gastroenterol Hepatol | 2024 | 39299667 | PubTator, text mining | PubMed |
| IVEA: an integrative variational Bayesian inference method for predicting enhancer-gene regulatory interactions. | Bioinform Adv | 2024 | 39193566 | PubTator, text mining | PubMed |
| Calcium-mediated DAD in membrane potentials and triggered activity in atrial myocytes of ETV1f / fMyHCCre /+ mice. | J Cell Mol Med | 2024 | 39159135 | PubTator, text mining | PubMed |
| Prostaglandin D2 receptor 2 downstream signaling and modulation of type 2 innate lymphoid cells from patients with asthma. | PLoS One | 2024 | 39052598 | PubTator, text mining | PubMed |
| 3D genomic analysis reveals novel enhancer-hijacking caused by complex structural alterations that drive oncogene overexpression. | Nat Commun | 2024 | 39033128 | PubTator, text mining | PubMed |
| CircPRELID2 functions as a promoter of renal cell carcinoma through the miR-22-3p/ETV1 cascade. | BMC Urol | 2024 | 38730434 | PubTator, text mining | PubMed |
| Genome-wide somatic mutation analysis of sinonasal adenocarcinoma with and without wood dust exposure. | Genes Environ | 2024 | 38711096 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implications. | Mol Cancer | 2024 | 38702773 | PubTator, text mining | PubMed |
| LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy. | Cell Death Dis | 2024 | 38388484 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2115/papers?page=4